GABA

Novel investigational postpartum depression pill showed rapid and significant improvement in depressive symptoms in Phase 3 clinical trial

Retrieved on: 
Mercoledì, Luglio 26, 2023
Mental Health, Research, Women, Clinical Trials, Health Insurance, Health, Consumer, Pharmaceutical, Science, GABA, PPD, Perseverance, JAMA, Depression, Diarrhea, NAS, Feinstein Institutes for Medical Research, Somnolence, COVID-19, Food and Drug Administration, Clinical trial, Urinary tract infection, Woman, DSM-IV codes, Multimedia, The American Journal of Psychiatry, Mother, American Medical Association, American Journal, Behavioural sciences, Dizziness, Journal, Patient, Zucker Hillside Hospital, Zuranolone, Grammatical mood, Nausea, Paper, FDA, Headache, Credit, Northwell Health, Safety, Medical research, Food, Female, Pharmaceutical industry, Birth control, MD, Psychiatry

Fourteen-day oral, at-home, treatment with zuranolone versus placebo resulted in statistically significant improvement in depressive symptoms, as measured by change from baseline in HAMD-17 total score.

Key Points: 
  • Fourteen-day oral, at-home, treatment with zuranolone versus placebo resulted in statistically significant improvement in depressive symptoms, as measured by change from baseline in HAMD-17 total score.
  • Results showed that 57 percent of the women taking zuranolone versus 38 percent of women taking placebo experienced a 50 percent or more improvement in their depressive symptoms at day 15.
  • The trial demonstrated the improvement in depressive symptoms with zuranolone at 30 mg versus placebo in patients with PPD and that zuranolone was generally well tolerated.
  • The SKYLARK and ROBIN clinical trials provide some of the most substantial results for improving depressive symptoms in women with PPD.

Miss Universe Launches M*U Beverage, the First Spin-Off Commercial Line Encompassing Ready-To-Drink Functional Beverages and Natural Alkaline Mineral Water Sourced Exclusively from Iceland.

Retrieved on: 
Martedì, Luglio 18, 2023
Universe, GABA, Miss Universe, Drink, Life, B vitamins, MUO, Stock Exchange of Thailand, Magnesium, F&B, Anxiety, Stock, Stock exchange, Immunity, Woman, JKN18, Miss Universe Thailand 2021, Research, Caffeine, Calcium, Branched-chain amino acid aminotransferase, Ready, Sustenance, Immune system, Vitamin C, MISS, United Kingdom, Nutritionist, Sodium, Imagination, Potassium, Empowerment, Social media, Dressmaker, Typesetting, Management, Tea, Soft drink, Bottled water, Tourism

We worked alongside nutritionists and natural ingredients experts to research, test, and produce products that energize, refresh, and rejuvenate minds and bodies," added Anne.

Key Points: 
  • We worked alongside nutritionists and natural ingredients experts to research, test, and produce products that energize, refresh, and rejuvenate minds and bodies," added Anne.
  • M*U functional drinks are made from natural ingredients, containing zero caffeine, no sugar, no preservatives and less than 45 kcal/bottle.
  • M*U Beverage is also excited to launch M*U NØR Natural Alkaline Mineral Water, the first alkaline water offered in a bespoke glass bottle and bottled in Thailand.
  • MISS UNIVERSE® programs provide the 10,000 women who participate annually an international platform to affect positive change through influential humanitarian and professional efforts.

Miss Universe launches M*U Beverage, the first spin-off commercial line encompassing Ready-To-Drink Functional beverages and Natural Alkaline Mineral Water sourced exclusively from Iceland.

Retrieved on: 
Martedì, Luglio 18, 2023
Universe, GABA, Miss Universe, Drink, Life, B vitamins, Health, MUO, Stock Exchange of Thailand, Magnesium, F&B, Anxiety, Stock, Stock exchange, Immunity, Woman, JKN18, Research, Caffeine, Lesbian and Gay Inter-University Organization, Calcium, Branched-chain amino acid aminotransferase, Ready, Sustenance, Immune system, Vitamin C, MISS, United Kingdom, Nutritionist, Sodium, Imagination, Potassium, Empowerment, Social media, Dressmaker, Management, Tea, Soft drink, Bottled water, Tourism

We worked alongside nutritionists and natural ingredients experts to research, test, and produce products that energize, refresh, and rejuvenate minds and bodies," added Anne.

Key Points: 
  • We worked alongside nutritionists and natural ingredients experts to research, test, and produce products that energize, refresh, and rejuvenate minds and bodies," added Anne.
  • M*U functional drinks are made from natural ingredients, containing zero caffeine, no sugar, no preservatives and less than 45 kcal/bottle.
  • M*U Beverage is also excited to launch M*U NØR Natural Alkaline Mineral Water, the first alkaline water offered in a bespoke glass bottle and bottled in Thailand.
  • MISS UNIVERSE® programs provide the 10,000 women who participate annually an international platform to affect positive change through influential humanitarian and professional efforts.

Oomph Body's Natural Sleep Aids Beat Pharmaceutical Alternatives

Retrieved on: 
Giovedì, Giugno 29, 2023
GABA, Mayo Clinic, Sleep deprivation, National Sleep Foundation, Sleep, Insomnia, Sharp, Dizziness, Dietary supplement, Nausea, Choline, Health, FDA, Conditional sentence, The Speed of Life, Pharmaceutical industry, Zolpidem

FORT LAUDERDALE, Fla., June 29, 2023 /PRNewswire/ -- Insomnia is a common struggle. As much as 33% of adults struggle with significant sleep deprivation, while one in 10 adults is considered to have chronic insomnia as a medical condition.

Key Points: 
  • But Sleep Foundation reports nearly twenty different potential side effects that come from taking sleep medications, including nausea, dizziness, and even uncontrollable shaking.
  • This struggle between insomnia and the side effects of sleep medications is what led the health and wellness brand Oomph Body to develop its Lights Out and Deep Sleep aminos products.
  • Both dietary supplements use natural ingredients like GABA and Choline Bitartrate to help improve quality of sleep and parasympathetic nervous system function, respectively, leading to a better night's sleep.
  • As is the case with all of Oomph Body's supplements, Deep Sleep and Lights Out offer the brand's customers a clean, natural alternative to harmful pharmaceutical-grade products.

Ovid Therapeutics Expands Its Scientific Leadership Team & Appoints Chief Strategy Officer

Retrieved on: 
Mercoledì, Giugno 28, 2023
Columbia University, SAB, Seizure, Postdoctoral researcher, Epilepsy, GABA, Pain disorder, Meg, Corporate Affairs, Doctor of Philosophy, MB, Rockefeller University, CSO, G&A, Research, CMO, CNS, GlaxoSmithKline Pharmaceuticals, Thought, Retirement, Syneos Health, ROCK2, Hemangioma, Vertex Pharmaceuticals, KCC2, Medical device, Pharmaceutical industry, Management

“We are excited as Zhong and Manoj respectively assume research and development leadership of Ovid’s focused pipeline of potential first-in-class and best-in-class CNS programs,” said Jeremy Levin, D. Phil, MB BChir, Chairman and Chief Executive Officer of Ovid Therapeutics.

Key Points: 
  • “We are excited as Zhong and Manoj respectively assume research and development leadership of Ovid’s focused pipeline of potential first-in-class and best-in-class CNS programs,” said Jeremy Levin, D. Phil, MB BChir, Chairman and Chief Executive Officer of Ovid Therapeutics.
  • Prior to joining Ovid, Dr. Zhong served in senior leadership and scientific roles at Generation Bio, Wave Life Sciences, Vertex Pharmaceuticals, and GlaxoSmithKline Pharmaceuticals.
  • Dr. Zhong will partner closely with Dr. Manoj Malhotra who is taking on an expanded role as Chief Medical Officer.
  • In addition to deepening its bench of scientific leadership, Ovid expanded the role of Meg Alexander to the position of Chief Strategy Officer.

Neuro Gum Enters New Era of Growth, Expands National Retail Footprint

Retrieved on: 
Mercoledì, Giugno 21, 2023
Honey, Taste, GABA, Ginger, CVS, Walmart, Food marketing, Meijer, D3, Albertson, Vitality, Cinnamon, Soft drink, Amazon, Neuro

LOS ANGELES, June 21, 2023 /PRNewswire/ -- Neuro, the company offering functional gum and mints with balanced energy, focus and clarity, is pleased to announce the expansion of its products into 250 Albertson's stores across the country. With this latest retail expansion, Neuro Gum and Neuro Mints are now available in over 10,000 leading retailers nationwide including all Whole Foods Markets locations across the country, CVS, Walmart, Meijer and Amazon, among other popular retailers.

Key Points: 
  • With this latest retail expansion, Neuro Gum and Neuro Mints are now available in over 10,000 leading retailers nationwide including all Whole Foods Markets locations across the country, CVS, Walmart, Meijer and Amazon, among other popular retailers.
  • "Our mission has always been to help everyone do more and get more out of every day," said Kent Yoshimura, CEO and co-founder, Neuro.
  • Calm & Clarity mints are expertly developed with GABA, vitamin D3, and L-theanine to optimize composure and clarity of mind.
  • Neuro Gum and Neuro Mints use simple, healthy ingredients synergized to improve your state of mind.

Plexus Worldwide® Launches Plexus Sleep™

Retrieved on: 
Lunedì, Giugno 19, 2023
GABA, Melatonin, Mayo Clinic, Sleep, Attention, FOS, Food and Drug Administration Amendments Act of 2007, Philips, Sleep deprivation, Magnetic resonance, Health, Food, Disease, Pharmaceutical industry, Research

SCOTTSDALE, Ariz., June 19, 2023 /PRNewswire/ -- Plexus Worldwide (Plexus®), a leading direct selling health and wellness company, announced the launch of Plexus Sleep, a supplement that promotes quality, restorative sleep and helps maintain a healthy sleep cycle.*

Key Points: 
  • SCOTTSDALE, Ariz., June 19, 2023 /PRNewswire/ -- Plexus Worldwide (Plexus®), a leading direct selling health and wellness company, announced the launch of Plexus Sleep , a supplement that promotes quality, restorative sleep and helps maintain a healthy sleep cycle.
  • *
    Plexus Sleep contains 5 mg of melatonin, a hormone that plays a role in sleep, paired with 1.7 grams of gut-healthy prebiotic fiber FOS (fructooligosaccharides).
  • It is also formulated with ashwagandha, an adaptogenic herb, along with GABA, lemon balm extract, and L-tryptophan.
  • "We developed Plexus Sleep to address sleep from two approaches – ingredients that support healthy sleep patterns and prebiotic fibers that feed probiotic gut microbes.

Token Communities, Ltd. Announces Launch of its First Two Naturopathic Supplements

Retrieved on: 
Venerdì, Giugno 16, 2023
Blood pressure, Liver disease, GABA, Mineral, Glucose, Type 2 diabetes, Coenzyme Q10, Blood, Vitamin, Type 2, Silybum, Dietary supplement, Cryptocurrency

BRADENTON, Fla., June 16, 2023 (GLOBE NEWSWIRE) -- Token Communities, Ltd. (“Token Communities” or the “Company”), today announced that the Company has launched the first two of its naturopathic supplements in the Asia Markets. The Company has engaged seven distributors in China to distribute the Company’s products in seven different areas of China. The first product is our supplement that we refer to as “Detox.” This supplement is a revolutionary Type 2 diabetes supplement designed to significantly improve Type-2 diabetes. It contains many effective clinically-proven ingredients, such as milk thistle, CoQ10, GABA and others which can detox the fatty liver and improve the endocrine disorder and blood sugar ( glucose ) management. The second product is our supplement called “Cleaner.” This supplement is designed to clean blood lipids and impurities in blood vessels designed to lower blood pressure. This supplement contains apple cider vinegar, lemon extract along with a variety of other vitamins and minerals.  

Key Points: 
  • BRADENTON, Fla., June 16, 2023 (GLOBE NEWSWIRE) -- Token Communities, Ltd. (“Token Communities” or the “Company”), today announced that the Company has launched the first two of its naturopathic supplements in the Asia Markets.
  • The Company has engaged seven distributors in China to distribute the Company’s products in seven different areas of China.
  • “We are so pleased to announce that after working diligently for over one year the Company has announced the release of our first two supplements.
  • “With the initial launch of our first supplements in China we are excited to begin exploring potential distribution partners in North America.”

Iconic U.S. Mushroom Supplement Company VidaCap Ventures Into the World of Amanita Muscaria

Retrieved on: 
Mercoledì, Giugno 14, 2023
Psilocybin, GABA, Millennium, Capsule, Rigveda, Muscimol, Mindfulness, Mushroom, Amanita

Long known for their therapeutic single dose mushroom extract capsules, this will be VidaCap's first foray into the world of Amanita Muscaria Gummies .

Key Points: 
  • Long known for their therapeutic single dose mushroom extract capsules, this will be VidaCap's first foray into the world of Amanita Muscaria Gummies .
  • Amanita muscaria, also known as the 'fly agaric' mushroom, has been prized for millenia in Eastern culture thanks to its therapeutic action and mind-altering effects.
  • "We couldn't be more excited or proud to finally be venturing into the world of Amanita," said VidaCap founder Jeff Yauck.
  • To learn more about VidaCap's new Amanita muscaria mushroom products, visit the brand's official website at VidaCap.com .

atai Life Sciences Reports First Quarter 2023 Financial Results and Announces Pipeline Highlights and Updates

Retrieved on: 
Giovedì, Maggio 11, 2023
Well, Consensus, Psilocybin, Acceleration, PK, Insurance, GABA, DMT, Society, MCCB, PD, IV, D&O, Benzodiazepine, OTF, VAT, Anorexia nervosa, COMP, PTSD, G&A, Part, Accounting, Anxiety disorder, Patient, Investment, Administration, EEG, Biological Psychiatry (journal), Annual general meeting, Pivotal, CIAS, Entrepreneurship, Oxygen toxicity, Research and development, Research, R, TRD, Safety, Cognitive deficit, Pharmaceutical industry, Palladium, Bank, Surveying, Schizophrenia

The Company’s $250M cash position and committed term loan funding is expected to fund operations into 1H 2026.

Key Points: 
  • The Company’s $250M cash position and committed term loan funding is expected to fund operations into 1H 2026.
  • NEW YORK and BERLIN, May 11, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, reported first quarter 2023 financial results and provided corporate updates.
  • “This past quarter we made significant progress, including the dosing of the first patient with RL-007 in a randomized, placebo-controlled Phase 2 study.
  • In January 2023, Phase 1 results were announced from the study of GRX-917 in healthy volunteers.